Middle East and Africa Metastatic Cancer Drugs Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Cancer Type (Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, and Others), Route of Administration (Intravenous and Intramuscular), Drug Class (HER2 Inhibitors, Immune Checkpoint Inhibitors, PARP Inhibitors, Kinase Inhibitors, and Others), Product (Branded, Generics, and Biosimilars), and End User (Hospital, Specialty Clinic, and Others)
The Middle East and Africa metastatic cancer drugs market is expected to reach US$ 4,087.30 million by 2028 from US$ 3,309.92 million in 2021; it is estimated to grow at a CAGR of 3.1% from 2021 to 2028.
The market is characterized by the presence of big and small companies. To increase their market share, players are adopting many strategies such as product launches, regional expansions, and technological advancements. For instance, in 2020, Duke Cancer Institute launched a proof-of-concept clinical trial of a new drug for hormone receptor-positive breast cancer patients, whose disease has spread to bones. The investigational therapy—GMI-1359—targets both E-selection and CXCR4, normal inflammatory molecules that appear to play a role in tumor trafficking and metastasis to the bone. Continuous innovations and technological advancements are resulting in the introduction of safe and effective metastatic cancer drugs, leading to increased acceptance among patients and medical societies.Such factor of new startegies by various companies are increasing the market growth of metastatic cancer drugs.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the metastatic cancer drugs market growth in the coming years. The market is expected to grow at a good CAGR during the forecast period.
Middle East and Africa Metastatic Cancer Drugs Market Revenue and Forecast to 2028 (US$ Million)
Middle East and Africa Metastatic Cancer Drugs Market Segmentation
The market for Middle East and Africa metastatic cancer drugs market is segmented into cancer type , route of administration , drug class , product , and end user. Based on cancer type , the market is segmented into breast cancer, lung cancer, liver cancer, haematological cancer, brain cancer, prostate cancer, pancreatic cancer, and others. Based on route of administration, the market is bifurcated into intravenous and intramuscular. Based on drug class, the Middle East and Africa metastatic cancer drugs market is segmented into HER2 inhibitors, immune checkpoint inhibitors, parp inhibitors, kinase inhibitors, and others. Based on product, the market is segmented into branded, generics, and biosimilars. Based on end user, the market is segmented into hospital, specialty clinic, and others. By country, the Middle East and Africa metastatic cancer drugs market is segmented into Saudi Arabia , South Africa , the UAE, and Rest of Middle East and Africa.
Middle East and Africa Metastatic Cancer Drugs Market – Companies Mentioned
AbbVie Inc.; Amgen Inc. ; Bristol-Myers Squibb Company ; F. HOFFMANN-LA ROCHE LTD.; Novartis AG ; Astrazeneca ; MERCK KGaA ; Pfizer Inc. (Arena Pharmaceutical GmbH) ; and Johnson and Johnson Services, Inc. are among the leading companies in the Middle East and Africa metastatic cancer drugs market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Metastatic Cancer Drugs Market – By Cancer Type
1.3.2 Middle East and Africa Metastatic Cancer Drugs Market – By Route of Administration
1.3.3 Middle East and Africa Metastatic Cancer Drugs Market – By Drug Class
1.3.4 Middle East and Africa Metastatic Cancer Drugs Market – By Product
1.3.5 Middle East and Africa Metastatic Cancer Drugs Market – By End User
1.3.6 Middle East and Africa Metastatic Cancer Drugs Market – By Country
2. Middle East and Africa Metastatic Cancer Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Metastatic Cancer Drugs Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa– PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Metastatic Cancer Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Metastatic Cancer
5.1.2 Government Initiatives to Support Developments in Cancer Treatment
5.2 Market Restraints
5.2.1 High Cost of Oncology Drugs
5.3 Market Opportunities
5.3.1 Investments in Artificial Intelligence for Oncology Drug Development
5.4 Future Trends
5.4.1 Increase in Launch of Metastatic Cancer Drugs
5.5 Impact analysis
6. Middle East and Africa Metastatic Cancer Drugs Market –Country Analysis
6.1 Middle East and Africa Metastatic Cancer Drugs Market Revenue Forecast and Analysis
6.1.1 Middle East and Africa : Middle East and Africa Metastatic Cancer Drug Market - Revenue and Forecasts to 2028, (US$ Mn)
7. Middle East and Africa Metastatic Cancer Drug Market Analysis – By Cancer Type
7.1 Overview
7.2 Middle East and Africa Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)
7.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
7.3 Breast Cancer
7.3.1 Overview
7.3.2 Breast Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lung Cancer
7.4.1 Overview
7.4.2 Lung Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver Cancer
7.5.1 Overview
7.5.2 Liver Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Hematological Cancer
7.6.1 Overview
7.6.2 Haematological Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Brain Cancer
7.7.1 Overview
7.7.2 Brain Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Prostate Cancer
7.8.1 Overview
7.8.2 Prostate Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Pancreatic Cancer
7.9.1 Overview
7.9.2 Pancreatic Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East and Africa Metastatic Cancer Drug Market – By Route of Administration
8.1 Overview
8.2 Middle East and Africa Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)
8.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
8.3 Intravenous
8.3.1 Overview
8.3.2 Intravenous: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Intramuscular
8.4.1 Overview
8.4.2 Intramuscular: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Oral
8.5.1 Overview
8.5.2 Oral: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East and Africa Metastatic Cancer Drug Market – By Drug Class
9.1 Overview
9.2 Middle East and Africa Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)
9.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
9.3 HER2 Inhibitors
9.3.1 Overview
9.3.2 HER2 Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Immune Checkpoints Inhibitors
9.4.1 Overview
9.4.2 Immune Checkpoints Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.5 PARP Inhibitors
9.5.1 Overview
9.5.2 PARP Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Kinase Inhibitors
9.6.1 Overview
9.6.2 Kinase Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East and Africa Metastatic Cancer Drug Market – By Product
10.1 Overview
10.2 Middle East and Africa Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)
10.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
10.3 Branded
10.3.1 Overview
10.3.2 Branded: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Generics and Biosimilars
10.4.1 Overview
10.4.2 Generics and Biosimilars: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11. Middle East and Africa Metastatic Cancer Drug Market – By End User
11.1 Overview
11.2 Middle East and Africa Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)
11.2.1 Middle East & Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
11.3 Hospital
11.3.1 Overview
11.3.2 Hospitals: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Specialty Clinic
11.4.1 Overview
11.4.2 Specialty Clinics: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
12. Middle East and Africa Metastatic Cancer Drugs Market – Regional Analysis
12.1 Middle East and Africa: Metastatic Cancer Drugs Market
12.1.1 Overview
12.1.2 Middle East & Africa: Metastatic Cancer Drug Market, by Country, 2021 & 2028 (%)
12.1.2.1 Saudi Arabia: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 Saudi Arabia: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 Saudi Arabia Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.3 Saudi Arabia Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.4 Saudi Arabia Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.5 Saudi Arabia Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.6 Saudi Arabia: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
12.1.2.2 UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 UAE Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.3 UAE Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.4 UAE Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.5 UAE Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.6 UAE: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
12.1.2.3 South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 South Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.3 South Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.4 South Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.5 South Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.6 South Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
12.1.2.4 Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.2 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.3 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.4 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.5 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.6 Rest of Middle East & Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
13. Middle East and Africa Metastatic Cancer Drug Market –Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market, 2021-2028
13.3 Inorganic Developments
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 AbbVie Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Amgen Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bristol-Myers Squibb Company
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. HOFFMANN-LA ROCHE LTD.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Astrazeneca
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 MERCK KGaA
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc. (Arena Pharmaceutical GmbH)
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Johnson and Johnson Services, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa: Middle East and Africa Metastatic Cancer Drug Market - Revenue and Forecasts to 2028, (US$ Mn).
Table 2. Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 4. Middle East & Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 5. Middle East & Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. Middle East & Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. Saudi Arabia Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 10. Saudi Arabia Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 11. Saudi Arabia Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. UAE Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 13. UAE Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. UAE Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 15. UAE Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 16. UAE Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. South Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 18. South Africa Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 19. South Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 20. South Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 21. South Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Middle East & Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 25. Rest of Middle East & Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Middle East & Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 27. Recent Inorganic Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market
Table 28. Recent Organic Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market
Table 29. Glossary of Terms, Middle East and Africa Metastatic Cancer Drugs Market
LIST OF FIGURES
Figure 1. Middle East and Africa Metastatic Cancer Drugs Market Segmentation
Figure 2. Middle East and Africa Metastatic Cancer Drugs Market Overview
Figure 3. The PARP Inhibitors Segment Held The Largest Share of Drug Class Segment in Middle East and Africa Metastatic Cancer Drugs Market
Figure 4. Germany Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Middle East and Africa PEST Analysis
Figure 6. Expert Opinion
Figure 7. Middle East and Africa Metastatic Cancer Drugs Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa Metastatic Cancer Drugs Market – Revenue Forecast and Analysis – 2021- 2028
Figure 9. Middle East and Africa Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)
Figure 10. Breast Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Lung Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Liver Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hematological Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Brain Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Prostate Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Pancreatic Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Middle East and Africa Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)
Figure 19. Intravenous: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Intramuscular: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Oral: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East and Africa Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)
Figure 24. HER2 Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immune Checkpoints Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. PARP Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Kinase Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Middle East and Africa Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)
Figure 30. Branded: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Generics and Biosimilars: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Middle East and Africa Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)
Figure 33. Hospitals: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Specialty Clinics: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Middle East and Africa: Metastatic Cancer Drugs Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 37. Middle East & Africa: Metastatic Cancer Drug Market, by Country, 2021 & 2028 (%)
Figure 38. Saudi Arabia: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market, 2021-2028
- AbbVie Inc.
- Amgen Inc.
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- Novartis AG
- Astrazeneca
- MERCK KGaA
- Pfizer Inc. (Arena Pharmaceutical GmbH)
- Johnson and Johnson Services, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East and Africa Metastatic Cancer Drugs Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Middle East and Africa Metastatic Cancer Drugs Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.